Comprehensive risk management for the prevention of cerebro-cardiovascular diseases in Japan Joint Committee for Comprehensive Risk Management Chart for the Prevention of Cerebro-Cardiovascular Diseases Special article 03 October 2017 Pages: 743 - 754
Treatment of pediatric-onset lupus nephritis: a proposal of optimal therapy Hiroshi TanakaKensuke JohTadaatsu Imaizumi Review article 03 March 2017 Pages: 755 - 763
Treatment of HCV in renal transplant patients with peginterferon and ribavirin: long-term follow-up Siu-ka MakHo-kwan SinAndrew K. M. Wong Original article 12 January 2017 Pages: 764 - 770
Valproic acid attenuates renal fibrosis through the induction of autophagy Koichiro KawaokaShigehiro DoiTakao Masaki Original Article 07 December 2016 Pages: 771 - 780
Asymptomatic circulating T-cell clone cause renal polymorphic inflammatory fibrosis David RibesAudrey CasemayouStanislas Faguer Original article 26 December 2016 Pages: 781 - 786
Impact of the CYP3A5 genotype on the distributions of dose-adjusted trough concentrations and incidence of rejection in Japanese renal transplant recipients receiving different tacrolimus formulations Takenori NiiokaHideaki KagayaMasatomo Miura Original article 07 March 2017 Pages: 787 - 796
The cardiothoracic ratio and all-cause and cardiovascular disease mortality in patients undergoing maintenance hemodialysis: results of the MBD-5D study Hiroaki OgataJunji KumasawaTadao Akizawa Original article Open access 15 May 2017 Pages: 797 - 806
Erratum to: The cardiothoracic ratio and all-cause and cardiovascular disease mortality in patients undergoing maintenance hemodialysis: results of the MBD-5D study Hiroaki OgataJunji KumasawaTadao Akizawa Erratum 04 July 2017 Pages: 807 - 808
Erratum to: The cardiothoracic ratio and all-cause and cardiovascular disease mortality in patients undergoing maintenance hemodialysis: results of the MBD-5D study Hiroaki OgataJunji KumasawaTadao Akizawa Erratum 07 September 2017 Pages: 809 - 809
Relationship between exercise capacity and urinary liver-type fatty acid-binding protein in middle-aged and older individuals Keisei KosakiAtsuko Kamijo-IkemoriSeiji Maeda Original article 14 February 2017 Pages: 810 - 817
Usefulness of combination therapy with Daclatasvir plus Asunaprevir in chronic hepatitis C patients with chronic kidney disease Norihiko MorisawaYohei KoshimaMorimasa Amemiya Original article 22 October 2016 Pages: 818 - 824
Possible prevention of uremic nausea by vitamin D receptor activators in non-dialysis patients with stage 5 chronic kidney disease Masato IkedaYoshimi UedaTakashi Shigematsu Original article Open access 14 November 2016 Pages: 825 - 834
Association between gamma-glutamyltransferase and albuminuria in nondiabetic adults with normal renal function Sun-Hye KoMyong Ki BaegYu-Bae Ahn Original article 09 December 2016 Pages: 835 - 841
Long-term outcomes of initial therapy for idiopathic membranous nephropathy Masayo SatoTakashi TakeiKosaku Nitta Original article 20 December 2016 Pages: 842 - 851
The discrepancy between serum creatinine and cystatin C can predict renal function after treatment for postrenal acute kidney injury: multicenter study and pooled data analysis Masahiro MatsukiToshiaki TanakaNaoya Masumori Original article 03 March 2017 Pages: 852 - 857
Effects of tolvaptan in patients with chronic kidney disease and chronic heart failure Mari KatsumataNobuhito HirawaSatoshi Umemura Original article Open access 11 February 2017 Pages: 858 - 865
Acid–base disturbances in nephrotic syndrome: analysis using the CO2/HCO3 method (traditional Boston model) and the physicochemical method (Stewart model) Tomomichi KasagiHirokazu ImaiShogo Banno Original article Open access 13 March 2017 Pages: 866 - 876
Female X-linked Alport syndrome with somatic mosaicism Kana YokotaKandai NozuKazumoto Iijima Original article 31 October 2016 Pages: 877 - 883
The true distribution volume and bioavailability of mizoribine in children with chronic kidney disease Takuhito NagaiOsamu UemuraYukiya Hashimoto Original article 21 November 2016 Pages: 884 - 888
Clinical characteristics and long-term outcome of diarrhea-associated hemolytic uremic syndrome: a single center experience Takeshi NinchojiKandai NozuKazumoto Iijima Original article 10 January 2017 Pages: 889 - 894
A new peritoneal dialysis fluid for Japanese patients: a randomized non-inferiority clinical trial of safety and efficacy Masaaki NakayamaYoshindo KawaguchiMark R. Marshall Original article Open access 25 October 2016 Pages: 895 - 907
Effects of lanthanum carbonate and calcium carbonate on fibroblast growth factor 23 and hepcidin levels in chronic hemodialysis patients Yu-Ming ChangShih-Ching TsaiYa-Ting Huang Original article 07 December 2016 Pages: 908 - 916
Erratum to: Effects of lanthanum carbonate and calcium carbonate on fibroblast growth factor 23 and hepcidin levels in chronic hemodialysis patients Yu-Ming ChangShih-Ching TsaiYa-Ting Huang Erratum 23 February 2017 Pages: 917 - 918
Quality of life of elderly patients on peritoneal dialysis versus hemodialysis: a single-center study Yosuke SakaTomohiko NaruseYasuhiko Ito Original article 20 December 2016 Pages: 919 - 925
Hyperparathyroidism and increased fractional excretion of phosphate predict allograft loss in long-term kidney transplant recipients Sumanee PrakobsukSupinda SirilakSinee Disthabanchong Original article 16 December 2016 Pages: 926 - 931
Circulating and renal expression of HLA-G prevented chronic renal allograft dysfunction in Japanese recipients Yuki OkushiKazuaki OkinoHitoshi Yokoyama Original article 31 March 2017 Pages: 932 - 940
Heterozygous Fabry disease complicated by acute onset paralysis Yoichi IwafuchiYuko OyamaIchiei Narita Images in Nephrology 31 October 2016 Pages: 941 - 942
